Watts Barbara
Tri-County Internal Medicine, 807 Jackson Trace Road, Wetumpka, AL 36092, USA.
J Am Acad Nurse Pract. 2009 May;21(5):261-9. doi: 10.1111/j.1745-7599.2009.00403.x.
To increase awareness among nurse practitioners (NPs) regarding diagnostic and treatment guidelines for asthma for the 5-11 year age group recently updated by the National Asthma Education Prevention Program-Expert Panel 3 (NAEPP-EPR3).
NAEPP-EPR3 guidelines for the diagnosis and management of asthma released from the National Heart, Lung, and Blood Institute in August 2007, selected clinical trials, meta-analyses, and clinical reviews.
Recent research has revealed that children suffering from asthma in the United States are underdiagnosed and their asthma is poorly controlled. Compelling evidence supports that children classified as having persistent asthma following NAEPP-EPR3 guidelines benefit from daily inhaled corticosteroid therapy, yet many are misclassified and undertreated.
With application of current guidelines from NAEPP-EPR3, NPs can more effectively assess, diagnose, treat, and foster a collaborative self-management plan for children age 5-11 years. These interventions will result in an improved quality of life and decreased health risks for this young population.
提高执业护士对国家哮喘教育与预防计划专家小组3(NAEPP-EPR3)最近更新的5至11岁年龄组哮喘诊断和治疗指南的认识。
2007年8月美国国立心肺血液研究所发布的NAEPP-EPR3哮喘诊断和管理指南、选定的临床试验、荟萃分析和临床综述。
最近的研究表明,美国患有哮喘的儿童诊断不足且哮喘控制不佳。有力证据支持,按照NAEPP-EPR3指南被归类为持续性哮喘的儿童可从每日吸入糖皮质激素治疗中获益,但许多儿童被错误分类且治疗不足。
通过应用NAEPP-EPR3的现行指南,执业护士可以更有效地评估、诊断、治疗5至11岁儿童,并促进制定协作性自我管理计划。这些干预措施将改善这一年轻人群的生活质量并降低健康风险。